FC
BPMC

FORA Capital’s Blueprint Medicines BPMC Stock Holding History

FORA Capital’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,589
Closed -$1.61M – 498
2025
Q2 		$1.61M Buy
+12,589
New +$1.31M 0.18% 145
2024
Q1 		– Sell
-24,306
Closed -$2.24M – 418
2023
Q4 		$2.24M Buy
+24,306
New +$1.57M 0.19% 144
2022
Q4 		– Sell
-3,185
Closed -$210K – 476
2022
Q3 		$210K Buy
+3,185
New +$205K 0.04% 381
2022
Q1 		– Sell
-2,773
Closed -$297K – 520
2021
Q4 		$297K Buy
+2,773
New +$290K 0.12% 226
2021
Q3 		– Sell
-715
Closed -$63K – 424
2021
Q2 		$63K Buy
+715
New +$65.5K 0.01% 678
2021
Q1 		– Sell
-4,185
Closed -$469K – 794
2020
Q4 		$469K Buy
4,185
+1,782
+74% +$188K 0.07% 300
2020
Q3 		$223K Sell
2,403
-237
-9% -$18.3K 0.15% 155
2020
Q2 		$206K Buy
+2,640
New +$179K 0.07% 331
2020
Q1 		– Sell
-848
Closed -$68K – 1052
2019
Q4 		$68K Buy
+848
New +$63.5K 0.01% 836

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

FORA Capital's BPMC Position: Q3 2025 in Review

FORA Capital sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 12,589 shares — an estimated $1.61M sold.

FORA Capital first reported a position in BPMC in Q4 2019 and held it in 9 quarters. The position peaked at $2.24M in Q4 2023. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • FORA Capital reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • FORA Capital sold 12,589 Blueprint Medicines shares in Q3 2025, an estimated $1.61M.
  • FORA Capital first reported a position in Blueprint Medicines in Q4 2019 and held it in 9 quarters.
  • FORA Capital's Blueprint Medicines position peaked at $2.24M in Q4 2023.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on FORA Capital's 13F filing for Q3 2025, filed 13 Nov 2025.